sales and profits

Bayer to Buy U.S. Vitamin Maker Schiff for $1.2 Billion

Dr. Reddy's Q2 Profit Jumps on New Drugs

Anadarko Petroleum Has Quarterly Profit

Tax Gains Lift Merck & Co Q3 Profits

LyondellBasell to Pay Special Dividend Despite Decline in Profit

Occidental, Conoco Q3 Profits Fall on Lower Prices

BASF Bolstered by Libyan Oil and Pesticides

Biogen Q3 Profit Rises

Celgene Profit Beats Forecasts as Revlimid Delivers

Sanofi Sees Relief from Patent Loss Pain

Speciality Plastics and Consumer Chemicals Boost Solvay

Dow Chemical CEO Vows to Hit Profit Target Despite Cuts

New CEO Has Work Cut Out as AstraZeneca Sales Fall

Siam Cement Ups 2012 Cement Sales Forecast

Amgen Q3 Profits Up

Dow Cutting Jobs, Closing Plants as Growth Slows

DuPont to Cut 1,500 Jobs as Economic Storm Worsens

Air Products Q4 Profit Drops

Actavis Forecasts 2012 Sales in Excess of €2 Billion

Cost Cuts Help PPG Industries Q3 Profits

Focus on New Actelion Drug as Tracleer Sales Slip

AkzoNobel Takes Big Hit on Dulux as Home Makeovers Wane

Abbott Q3 Profit Tops View

Saudi SABIC Q3 profit drops 23%

J&J Q3 Profit Beats View as Drug Sales Rebound

Roche Sees More Cancer Success as Sales Top Forecast

Monsanto Posts Q4 Loss as Corn Seeds Sales Slip

Cefic Appoints BASF Chairman Bock New President

Sinopec Sees Rising Demand in Second Half

PetroChina Plans Overseas Investments while Q2 profit slides

CNOOC Profit Slides, Cuts Dividend ahead of Canadian Buy

Merck KGaA Beats in Q2 on Rebif Drug

Oxea Reports Robust Earnings and Strong Cash Flows

Oxea, a global supplier of Oxo Intermediates and Oxo Derivatives, today announced robust earnings for the second quarter of 2012, with net sales of €380 million getting close to prior year's level.

Brenntag Grows in Q2 2012 in More Difficult Market Conditions

Neuland Labs Reports Q1 2013 Financial Results